Flow cytometry analysis of the tumor immune landscape in transplanted tumors revealed that KDM4C inhibition could significantly increase the proportion of CD8+ T cells (figure 1E, F and online supplemental figure S2). This evidence concerns the gene KDM4C and neoplasm.